(Case Western Reserve University) Case Western Reserve University has granted an 18-month, exclusive option to startup Thermalin Diabetes Inc. regarding a portfolio of insulin analogs.
The company must reach certain milestones in order to exercise its option to obtain an exclusive license on therapies designed to help patients with diabetes.
Cleveland-based Thermalin Diabetes is developing treatments that it hopes will become an important part of the $12 billion, rapidly growing insulin market.
Post new comment